ÂÜÀòÂÒÂ×

Ronald Jubin has over 30 years of work experience in the pharmaceutical and biotechnology industries. In 1990, they began their career as a Scientist II at the Schering-Plough Research Institute, where they were responsible for discovering antiviral drugs. In 2004, they moved to PBL InterferonSource as the R & D Director, leading all aspects of new product development from conception to marketing. In 2012, they became a Consultant at Integrated Resources. In 2013, they took on the role of Vice President Innovation at Prolong Pharmaceuticals, where they were responsible for leading the Applied Research and Development of novel PEGylated Therapeutics. In 2014, they became the Scientific Founder of IES Life Sciences, Inc., where they identified and developed novel diagnostics for conditions of unmet clinical needs.

Ronald Jubin obtained a Ph.D. in Microbiology and Molecular Genetics from Rutgers Robert Wood Johnson Medical School (UMDNJ), an M.S. in Microbiology from Seton Hall University, and a B.A. in Microbiology from Kean University.